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A B S T R A C T
Background
Demineralised white lesions (DWLs) can appear on teeth during fixed brace treatment because of early decay around the brackets that
attach the braces to the teeth. Fluoride is effective in reducing decay in susceptible individuals in the general population. Individuals
receiving orthodontic treatment may be prescribed various forms of fluoride treatment. This review compares the effects of various
forms of fluoride used during orthodontic treatment on the development of DWLs. This is an update of a Cochrane review first
published in 2004.
Objectives
The primary objective of this review was to evaluate the effects of fluoride in reducing the incidence of DWLs on the teeth during
orthodontic treatment.
The secondary objectives were to examine the effectiveness of different modes of fluoride delivery in reducing the incidence of DWLs,
as well as the size of lesions. Participant-assessed outcomes, such as perception of DWLs, and oral health-related quality of life data
were to be included, as would reports of adverse effects.
Search methods
We searched the Cochrane Oral Health Group’s Trials Register (to 31 January 2013); the Cochrane Central Register of Controlled
Trials (CENTRAL) (The Cochrane Library 2012, Issue 12); MEDLINE via OVID (1946 to 31 January 2013); and EMBASE via OVID
(1980 to 31 January 2013).
Selection criteria
We included trials if they met the following criteria: (1) parallel-group randomised clinical trials comparing the use of a fluoride-
containing product versus placebo, no treatment or a different type of fluoride treatment, in which (2) the outcome of enamel
demineralisation was assessed at the start and at the end of orthodontic treatment.
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Data collection and analysis
At least two review authors independently, in duplicate, conducted risk of bias assessments and extracted data. Authors of trials were
contacted to obtain missing data or to ask for clarification of aspects of trial methodology. The Cochrane Collaboration’s statistical
guidelines were followed.
Main results
For the 2013 update of this review, three changes were made to the protocol regarding inclusion criteria. Fourteen studies included in
the previous version of the review were excluded from this update for the following reasons: five previously included studies were quasi-
randomised, a further five were split-mouth studies, three measured outcomes on extracted teeth only and in one, the same fluoride
intervention was used in each intervention group of the study.
Three studies and 458 participants were included in this updated review. One study was assessed at low risk of bias for all domains, in
one study the risk of bias was unclear and in the remaining study, the risk of bias was high.
One placebo-controlled study of fluoride varnish applied every six weeks (253 participants, low risk of bias), provided moderate-quality
evidence of an almost 70% reduction in DWLs (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.21 to 0.44, P value < 0.001).
This finding is considered to provide moderate-quality evidence for this intervention because it has not yet been replicated by further
studies in orthodontic participants.
One study compared two different formulations of fluoride toothpaste and mouthrinse prescribed for participants undergoing or-
thodontic treatment (97 participants, unclear risk of bias) and found no difference between an amine fluoride and stannous fluoride
toothpaste/mouthrinse combination and a sodium fluoride toothpaste/mouthrinse combination for the outcomes of white spot index,
visible plaque index and gingival bleeding index.
One small study (37 participants) compared the use of an intraoral fluoride-releasing glass bead device attached to the brace versus a
daily fluoride mouthrinse. The study was assessed at high risk of bias because a substantial number of participants were lost to follow-
up, and compliance with use of the mouthrinse was not measured.
Neither secondary outcomes of this review nor adverse effects of interventions were reported in any of the included studies.
Authors’ conclusions
This review found some moderate evidence that fluoride varnish applied every six weeks at the time of orthodontic review during
treatment is effective, but this finding is based on a single study. Further adequately powered, double-blind, randomised controlled trials
are required to determine the best means of preventing DWLs in patients undergoing orthodontic treatment and the most accurate
means of assessing compliance with treatment and possible adverse effects. Future studies should follow up participants beyond the
end of orthodontic treatment to determine the effect of DWLs on participant satisfaction with treatment.
P L A I N L A N G U A G E S U M M A R Y
Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Review question
Ugly white marks sometimes appear on the teeth during orthodontic (brace) treatment. These are caused by early tooth decay and
usually occur with fixed (or glued-on ’train track’) braces when the teeth are not cleaned properly.
We know that fluoride in toothpaste helps to prevent dental decay; therefore, extra fluoride provided to people wearing braces should
protect them from these marks. This review, produced by the Cochrane Oral Health Group, examines the evidence for this in existing
research. The aim of this review is to assess the effectiveness of fluorides in preventing early tooth decay during orthodontic (brace)
treatment and to determine the best way to do this.
Background
Early tooth decay around the brackets that attach braces to the teeth can cause white or brown marks (demineralised white lesions
(DWLs)) to appear on teeth during fixed brace treatment. Build-up of dental plaque around these brackets is associated with increased
risk of rapid demineralisation of the enamel of teeth. Demineralisation is an early, but reversible, stage in the development of tooth
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decay. Wearing of fixed braces may be associated with pain, and both the brace and the pain make toothbrushing more difficult, which
in turn means that it is harder to prevent the build-up of plaque. People often wear braces for 18 months or longer, and there is a risk
that tooth decay will damage the teeth, requiring restorations and fillings to be done.
Fluoride is effective in reducing tooth decay in people who are at risk of developing it. Individuals receiving orthodontic treatment may
be prescribed various forms of fluoride treatment. It is important to consider how the fluoride is to be applied and whether children
and adolescents (receiving fixed brace treatment) are likely to be willing and able to regularly apply by themselves the amounts needed
to prevent early tooth decay.
Study characteristics
The evidence on which this review is based was up-to-date as of 31 January 2013. Three studies with 458 participants were included in
this updated review. Participants were undergoing orthodontic treatment with fixed braces, and DWLs were assessed on teeth remaining
in the mouth at the end of orthodontic treatment.
The different ways of applying fluoride that were assessed included:
1. topical fluorides, for example, fluoride-containing varnish, mouthrinse, gel or toothpaste;
2. fluoride-releasing devices attached to the braces; and
3. control group approaches - individuals did not receive additional fluoride as described, or they received a placebo or a different form
of fluoride.
Key results
One study showed that when the dentist paints fluoride-containing varnish around the teeth and brace every time it is adjusted, the
risk of developing white marks is reduced by nearly 70%; however, further well-designed trials are required to confirm this finding.
The rest of the evidence is weak, and more studies are needed to show the best way of delivering extra fluoride to people wearing braces.
Adverse effects or harms of interventions were not reported in any of the included studies.
Quality of the evidence
The quality of the evidence found is moderate in the case of one well-designed study and weak in the remaining studies. Recommen-
dations state that further well-conducted research should be conducted in this area.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Fluoride varnish versus placebo varnish for the prevention of demineralised white lesions on teeth during fixed brace treatment
Patient or population: Participants undergoing orthodontic treatment with fixed appliances
Settings: Orthodontic practice
Intervention: Fluoride varnish
Comparison: Placebo varnish
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Placebo varnish Fluoride varnish
Number of patients
with new demineralised
white lesions
Study population RR 0.31
(0.21 to 0.44)
253
(1 study)
⊕⊕⊕©
moderate1
640 per 1000 198 per 1000
(134 to 282)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 A single study with 253 participants evaluated this outcome. Risk of bias was assessed as low. However, this finding should be
interpreted with caution until the study has been replicated.
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B A C K G R O U N D
Description of the condition
During orthodontic treatment with fixed appliances, brackets are
attached to the teeth to hold the wires that provide the forces re-
quired to straighten the teeth. One of the adverse effects of fixed
braces is that dental plaque collects around the attachments, lead-
ing to accumulation of the types of bacteria that cause dental dis-
ease (Naranjo 2006). Build-up of dental plaque around orthodon-
tic brackets is associated with increased risk of demineralised white
lesions (DWLs), which can be visible within six months (Tufekci
2011). Demineralisation is an early, but reversible, stage in the
development of dental decay (caries). Cariogenic bacteria present
in the dental plaque transform sugar in the diet into organic acids,
which start to damage the tooth enamel. Effective removal of
plaque will prevent DWLs from occurring; however, the presence
of orthodontic appliances in themouth and associated dental pain
may make it more difficult for individuals to adequately clean
their teeth and braces. DWLs developing on the buccal surfaces of
teeth during orthodontic treatment can become a significant prob-
lem over the course of treatment, which may last for 18 months
or longer, resulting in a poor appearance of the teeth following
straightening (Maxfield 2012). In severe cases, caries can develop,
requiring restoration (filling); this may be both painful and costly.
A recent study by Enaia and colleagues (Enaia 2011) using clin-
ical photographs of the teeth taken before and after fixed brace
treatment found that the prevalence of DWLs was 32% in par-
ticipants before treatment; however, this proportion rose to 74%
after treatment. Most of the DWLs were minor, but a significant
minority of participants (10%) had cavities in their teeth, which
may have required a filling. Although DWLs tend to fade with
time as they heal, Ogaard 1989 found that, even five years after
treatment, orthodontic participants had a significantly higher in-
cidence of DWLs than a control group of participants who did
not undergo orthodontic treatment.
Description of the intervention
Orthodontists are keen to prevent the development of DWLs so
their patients may have the best possible outcome following or-
thodontic treatment - well-aligned caries-free teeth. Fluoride is
important in the prevention of dental decay (ten Cate 2013).
Marinho and colleagues (Marinho 2003) found a definite reduc-
tion in caries in children and adolescents who performed regular
supervised rinsing with a fluoride mouthwash. It has also been
shown that fluoridemay reduce the number ofDWLs that develop
during brace treatment. When orthodontic participants used a
mouthrinse, Geiger et al (Geiger 1992) found a 30% reduction in
the number of participants and a 25% reduction in the incidence
of teeth affected by DWLs. Many orthodontists recommend the
use of a daily fluoride mouthrinse throughout brace treatment to
prevent DWLs (Kerbusch 2012).
Several methods (in addition to fluoridated toothpaste) are used to
deliver fluoride to teeth in patients during orthodontic treatment.
These include the following.
• Topical fluorides (e.g. mouthrinse, gel, varnish).
• Fluoride-releasing materials (e.g. glues used to bond the
brackets onto the teeth and orthodontic elastics that are
impregnated with fluoride).
• Dietary fluoride supplementation (e.g. fluoridated milk).
How the intervention might work
Fluoride present in themouth reduces caries development via three
mechanisms: inhibition of the demineralisation of dental enamel,
enhancement of the remineralisation of dental enamel producing
a remineralised layer that is resistant to acid attack and inhibition
of the bacterial enzymes that produce the acid (Lynch 2006; ten
Cate 2013).
Most children undergoing orthodontic treatment will be exposed
to some fluoride - low concentrations in the water supply, higher
concentrations from fluoridated dentifrices (toothpaste), or both.
Use of additional topical fluorides and/or fluoride sources designed
to deliver additional fluoride to the at-risk area near orthodontic
brackets are likely to reduce the risk ofDWLdevelopment. Topical
fluorides include fluoride mouthrinses, varnishes, gels, dentifrices
and dietary sources (e.g. fluoridated milk). Specific orthodontic
sources of fluoride include bracket adhesives and orthodontic elas-
tic bands (elastomeric ligatures), which slowly release fluoride into
the mouth. All of these fluoride sources release fluoride into saliva
that is distributed throughout the mouth.
Why it is important to do this review
Several systematic reviews have investigated the effects of deliv-
ering fluoride in various modes on dental caries in children and
adolescents (Marinho 2003; Marinho 2003a; Marinho 2003b;
Marinho 2004); however, these systematic reviews did not exam-
ine the effects of fluoride on participants wearing fixed orthodon-
tic braces.
Some orthodontists routinely recommend to their patients the use
of fluoride mouthrinses. However, clear evidence is lacking regard-
ing the optimum concentration of fluoride inmouthrinses, the op-
timum frequency of mouthrinse use and the effects of mouthrinses
and other topical fluorides over the duration of orthodontic treat-
ment.
This is an update of a Cochrane review first published in 2004 to
summarise evidence of the effects of the use of any topical fluo-
ride on the prevention of demineralised white lesions in patients
undergoing orthodontic treatment.
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O B J E C T I V E S
The primary objective of this review was to evaluate the effects of
fluoride in reducing the incidence of demineralised white lesions
(DWLs) on the teeth during orthodontic treatment.
The secondary objectives were to examine the effectiveness of dif-
ferent modes of fluoride delivery in reducing the incidence of
DWLs, as well as the size of lesions. Participant-assessed outcomes,
such as perception of DWLs, and oral health-related quality of life
data were to be included, as would reports of adverse effects.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) in which top-
ical fluoride was delivered by any method to prevent enamel
demineralised white lesion (DWL) formation during orthodontic
treatment with fixed braces. As topical fluorides are distributed
throughout themouth by saliva, the use of a split-mouth study de-
sign to evaluate these interventions is inappropriate. (Split-mouth
studies included in the previous version of this review found no
difference between teeth with fluoridated bracket adhesives and
those without, supporting the view that this design is inappropri-
ate for evaluating topical fluorides.)We have excluded split-mouth
studies from the 2013 update of this review.
Types of participants
Included were participants of any age who were undergoing or-
thodontic treatment with fixed braces in situations where DWLs
were assessed on teeth remaining in the mouth at the end of or-
thodontic treatment (at debonding, immediately after the active
fixed brace is removed). We excluded studies that evaluated dem-
ineralisation of extracted teeth (ex vivo).
Types of interventions
• Topical fluoride in the form of toothpaste, mouthrinse, gel,
varnish or dietary sources at any dose, frequency, duration or
method of administration, and with any of the following active
agents/ingredients: NaF (sodium fluoride), SMFP (sodium
monofluorophosphate), SnF (stannous fluoride), APF
(acidulated phosphate fluoride) and amine F (amine fluoride).
• Materials containing fluoride that is released during
treatment, including fluoride-releasing composite resin-bonding
materials, glass ionomer cements, compomers and resin-
modified glass ionomers for bonding or banding, slow-release
fluoride devices and fluoride-releasing elastomeric ligatures.
• The control group comprises individuals not subjected to
the fluoride intervention but instead treated with a placebo, such
as a non-fluoride toothpaste and mouthrinse, or given no
intervention. Studies involving a control subjected to an
alternative fluoride intervention were also included.
Types of outcome measures
Primary outcomes
• The outcome measure was the presence/absence of new
DWLs by participant. This can be assessed directly from the
participant or preferably from start and finish photographs or
fluorescent images of the teeth (immediately after the active fixed
brace is removed). If the number of DWLs was not recorded at
the start of treatment, the outcome was the presence or absence
of DWLs at the end of the orthodontic treatment period, again
assessed directly from the participant or indirectly from
photographs or fluorescent images of the teeth.
Secondary outcomes
• Differences in size and severity of DWLs between
experimental and control groups.
• Any quantitative assessment of enamel mineral loss, such as
fluorescent light techniques or microradiography, used with in
situ caries models (Benson 2010).
• Any participant-assessed outcomes, such as perception of
DWLs and oral health-related quality of life data.
• Adverse effects.
Search methods for identification of studies
For the identification of studies included or considered for this
review, detailed search strategies were developed for each database
searched. No restrictions were placed on the language of publica-
tion when searching the electronic databases. Searches were origi-
nally done in July 2003 and were undertaken again in May 2012
and January 2013 for this update of the review.
Electronic searches
We searched the following electronic databases.
• The Cochrane Oral Health Group’s Trials Register (to 31
January 2013) (Appendix 1).
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2012, Issue 12) (Appendix
2).
• MEDLINE via OVID (1946 to 31 January 2013)
(Appendix 3).
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• EMBASE via OVID (1980 to 31 January 2013) (Appendix
4).
Searching other resources
The bibliographies of identified RCTs and review articles were
checked for additional studies.
Unpublished studies
The US National Institutes of Health Trials Register
was searched in June 2013 for ongoing studies. Personal contacts
were used to identify unpublished RCTs.
Handsearching
The following journals were identified as important to be hand-
searched for this review.
• American Journal of Orthodontics and Dentofacial
Orthopedics
• The Angle Orthodontist
• European Journal of Orthodontics
• [British] Journal of Orthodontics
• Clinical Orthodontics and Research
• Journal of Dental Research
• Journal of Dentistry
• Caries Research
• Journal of Clinical Orthodontics.
These journals are included in the Cochrane Worldwide Hand-
searching Programme. See the Cochrane Masterlist for details of
issues searched to date. Only handsearching done as part of this
programme and uploaded to CENTRAL was included.
Data collection and analysis
Selection of studies
Two review authors independently examined the title, keywords
and abstract of reports identified through electronic searching for
evidence of three criteria.
• A randomised clinical trial of participants undergoing
orthodontic treatment.
• A trial comparing the use of a fluoride-containing product
versus no use or use of a non-fluoride control.
• A trial that assessed enamel demineralisation at the start and
at the end of orthodontic treatment.
For studies that appeared to meet the inclusion criteria, or for
which data in the title and abstract were insufficient to allow a
clear decision, the full report was obtained. Disagreements were
resolved by discussion.
No language restrictions were applied. Translations of foreign lan-
guage articles were produced by contacts within the Cochrane
Oral Health Group.
Data extraction and management
Data were extracted by two review authors independently, in du-
plicate, using specially designed data extraction forms. The data
extraction forms were piloted on several papers and were modified
as required before use. Any disagreementwas discussed, and a third
review author was consulted when necessary. All authors were con-
tacted for clarification of missing information. Data from studies
in which the reporting was incomplete were not included in the
analysis until the corresponding author of the study had supplied
adequate clarification. If agreement could not be reached, data
were excluded from the review. All studies that met the inclusion
criteria underwent validity assessment and data extraction. Stud-
ies rejected at this or subsequent stages were recorded, along with
reasons for exclusion, in the ’Characteristics of excluded studies’
table.
For each trial, the following data were recorded.
• Year of publication and country of origin.
• Study design.
• Unit of randomisation.
• Details of participants, including demographic
characteristics and criteria for inclusion.
• Details of types of interventions (method of delivery of
fluoride, dose, duration of use).
• Details of outcomes reported (number, size and severity of
white spot lesions), including method of assessment and mean
duration of the study.
Assessment of risk of bias in included studies
This assessment was conducted by using the recommended ap-
proach for assessing risk of bias in studies included in Cochrane
reviews (Higgins 2011). We used the two-part tool to address the
six specific domains (namely, sequence generation, allocation con-
cealment, blinding, incomplete outcome data, selective outcome
reporting and other bias). Each domain includes one or more spe-
cific entries in a ’Risk of bias’ table. Within each entry, the first
part of the tool involves describing what was reported to have hap-
pened in the study. The second part of the tool involves assigning
a judgement relating to the risk of bias for that entry: either low
risk, unclear risk or high risk.
The domains of sequence generation, allocation concealment, in-
complete outcome data and selective outcome reporting are ad-
dressed in the tool by a single entry for each study. For blinding,
two entries were used because assessments need to be made sepa-
rately for (1) participants and operators/orthodontists and (2) out-
come assessors. When the operator/orthodontist assessed the out-
come of the trial, this was noted. The final domain (’other sources
of bias’) was assessed as a single entry for studies as a whole.
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The risk of bias assessment was undertaken independently and
in duplicate by two review authors as part of the data extraction
process. Disagreements were resolved by discussion.
After taking into account additional information provided by the
authors of the trials, review authors grouped studies into the fol-
lowing categories.
Risk of bias Interpretation Within a study Across studies
Low risk of bias Plausible bias unlikely to seriously
alter the results
Low risk of bias for all key domains Most information comes from
studies at low risk of bias
Unclear risk of bias Plausible bias that raises some
doubt about the results
Unclear risk of bias for one or more
key domains
Most information comes from
studies at low or unclear risk of bias
High risk of bias Plausible bias that seriously weak-
ens confidence in the results
High risk of bias for one or more
key domains
The proportion of information
from studies at high risk of bias is
sufficient to affect the interpreta-
tion of results
A risk of bias table was completed for each included study. Results
were also presented graphically (Figure 1).
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Measures of treatment effect
For dichotomous outcomes, the estimate of effect of an interven-
tion was expressed as risk ratios (RRs) together with 95% con-
fidence intervals (CIs). For continuous outcomes, we estimated
mean differences (MDs) and 95% CIs.
Unit of analysis issues
In parallel-group trials in which participants are randomly as-
signed to intervention or to control and a single outcome measure
per participant is reported, the analysis is straightforward. When
individuals are randomly assigned to treatment, each individual
has a number of teeth exposed to the intervention or to the con-
trol. When the outcome is reported per number of teeth, the data
should be adjusted for clustering within the mouth of each in-
dividual to avoid unit of analysis errors. If it is unclear from the
reports of included trials whether clustering has been considered,
authors were contacted to clarify how this dependence has been
accounted for in the analysis.
Dealing with missing data
When data were not available in the printed report, or when data
were unclear, we contacted the corresponding author of the study
to obtain the missing data. The analysis generally includes only
available data (ignoring missing data); however, we would have
used methods of estimating missing standard deviations as pro-
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vided in Section 7.7.3 of theCochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011), if appropriate. Otherwise,
we did not undertake any imputations or use statistical methods
to allow for missing data.
Assessment of heterogeneity
Pooling of data andmeta-analysis were carried out only if sufficient
similarities were noted between studies in types of participants,
interventions and outcomes, including the time of the outcome
measurement. If any trials were pooled, the significance of dis-
crepancies in the estimates of treatment effects from the different
trials was to be assessed by using Cochran’s test for heterogeneity,
by which heterogeneity was considered significant if P value < 0.1
(Higgins 2011).
The I2 statistic, which describes the percentage total variation
across studies that is due to heterogeneity rather than to chance,
was used to quantify heterogeneity, with I2 greater than 50% con-
sidered to show substantial heterogeneity (Higgins 2011: Section
9.5.2).
Assessment of reporting biases
Only a proportion of research projects conducted are ultimately
published in an indexed journal and become easily identifiable for
inclusion in systematic reviews. Reporting biases arise when re-
porting of research findings is influenced by the nature and direc-
tion of the findings of the research.We investigated and attempted
to minimise in this review potential reporting biases, including
publication bias, time lag bias, multiple (duplicate) publication
bias and language bias.
If more than ten studies were included for one outcome, we would
have constructed a funnel plot. Any asymmetry in the funnel plot
indicating possible publication bias would have been investigated
by statistical analysis using themethods introduced by Egger 1997
(continuous outcome) and Rücker 2008 (dichotomous outcome)
(such analysis would have been done in STATA 11.0).
Data synthesis
Ameta-analysis was to be conducted only if studies of similar com-
parisons reported the same outcome measures. Risk ratios would
have been combined for dichotomous data and mean differences
for continuous data, using random-effects models, provided more
than three studies were included in the meta-analysis.
Subgroup analysis and investigation of heterogeneity
We planned to investigate clinical heterogeneity by examining
the different sources of fluoride. Provided sufficient studies were
identified for each intervention and outcome, we planned a pri-
ori to conduct subgroup analyses for different sources of fluoride
(mouthrinse, gel, varnish dentifrice, bracket adhesive, elastomeric
ligature).
Sensitivity analysis
It was planned to undertake sensitivity analyses to examine the
effects of quality assessment items on the assessment of overall
estimates of effect.
In addition, the effect on findings of the review of including un-
published literature was to be examined.
Summary of findings table
A ’Summary of findings’ table was developed for the primary out-
comes of this review using GRADEProfiler software. The quality
of the body of evidence was assessed with reference to the overall
risk of bias of the included studies, the directness of the evidence,
the inconsistency of the results, the precision of the estimates, the
risk of publication bias, the magnitude of the effect and whether
evidence of a dose response was found. The quality of the body
of evidence for each of the primary outcomes was categorised as
high, moderate, low or very low.
R E S U L T S
Description of studies
Results of the search
The original search identified 191 publications, of which 101 were
excluded after removal of duplicates and review of the title or ab-
stract. Full-text articles were obtained for the remaining 90. From
the 90 full articles, 58 references were assessed as ineligible for in-
clusion in this review. We contacted 18 study authors concerning
29 references. On the basis of information provided, 15 references
were excluded and three were pending further information, leav-
ing 14 trials, involving 613 participants, included in the original
version of this review.
For the 2013 update of this review, three changes to the protocol
regarding inclusion criteria resulted in the exclusion of all previ-
ously included studies. Five previously included quasi-randomised
trials were excluded (Banks 2000; Dyer 1982; Hirschfield 1978;
Millett 2000; Sonis 1989), five previously included split-mouth
studies were excluded (Chung 1998; Czochrowska 1998; Gillgrass
2001; Marcusson 1997; Twetman 1997) and three previously in-
cluded studies were excluded because outcomes were measured
ex vivo on extracted teeth (Gorton 2003; Øgaard 1986; Pascotto
2004). Øgaard 2001 was excluded because investigators compared
fluoride versus fluoride plus antiseptic.
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Three additional studies were identified by the updated search
(Luther 2005; Øgaard 2006; Stecksén-Blicks 2007), for a to-
tal of 458 participants included in the 2013 update of this re-
view. Three ongoing studies were identified (NCT01925924;
NCT00268138; NCT01768390).
For details of the studies examined and reasons for inclusion
or exclusion, please see Characteristics of included studies and
Characteristics of excluded studies tables.
Included studies
Three parallel-group randomised controlled trials (Luther 2005;
Øgaard 2006; Stecksén-Blicks 2007) were included in the update
of this review.
Characteristics of the trial participants and setting
Two of the included studies were conducted in Sweden (Øgaard
2006; Stecksén-Blicks 2007) and one in the United Kingdom
(Luther 2005). Two of the studies included adolescent participants
with an age range at baseline of 12 to 15 years, and the study by
Luther 2005 also included adults up to the age of 45 years. All
participants in the included trials were recruited at the start of
their orthodontic treatment with fixed appliances, and in all trials,
participants were followed until the end of treatment.
Characteristics of the interventions
One of the included studies was placebo-controlled (Stecksén-
Blicks 2007), and two conducted head-to-head comparisons.
We have grouped these trials into three comparisons.
• Fluoride-containing varnish versus non-fluoride-containing
placebo varnish (Stecksén-Blicks 2007).
• Amine fluoride and stannous fluoride toothpaste/
mouthrinse combination versus sodium fluoride toothpaste/
mouthrinse combination (Øgaard 2006).
• Intraoral fluoride-releasing glass bead device versus fluoride
mouthrinse (Luther 2005).
Characteristics of the outcomes
One of the studies reported the outcome of new demineralised
white lesions (DWLs) in each participant (Stecksén-Blicks 2007),
and one study (Luther 2005) planned to report this outcome but
actually reported only that no statistically significant difference
was observed between the groups. The third study (Øgaard 2006)
reported a white spot index.
None of the three included studies reported data for the secondary
outcomes of this review: differences in size and severity of DWLs,
quantitative assessment of enamel mineral loss, participant per-
ception of DWLs and any measure of oral health-related quality
of life, and adverse effects.
Excluded studies
A total of 57 studieswere excluded from this updated review for the
following reasons (for details, see the Characteristics of excluded
studies table).
• Split-mouth studies (Banks 1997; Buyukyilmaz 1994;
Chung 1998; Czochrowska 1998; Demito 2011; Gillgrass 2001;
Marcusson 1997; Mattick 2001; Millett 1999; Millett 2000;
Mitchell 1992; Shan 2008; Trimpeneers 1996; Turner 1993;
Twetman 1997; van der Linden 1998; Vivaldi-Rodrigues 2006).
• Not truly randomised (controlled clinical trials (CCTs))
(Banks 2000; Blanco 1988; Leizer 2010).
• Not randomised controlled trials (RCTs) (Boyles 2007;
Dyer 1982; Farhadian 2008; Fricker 1985; Fricker 1987;
Gaworski 1999; Geiger 1988; Geiger 1992; Hirschfield 1978;
Maijer 1988; Øgaard 1992; Øgaard 1996; Shannon 1978;
Shannon 1979; Sonis 1989; Underwood 1989; Wenderoth
1999).
• Outcomes reported on extracted teeth (ex vivo) (Gorton
2003; O’Reilly 1987; Øgaard 1986; Pascotto 2004).
• Outcomes assessed at the end of fluoride treatment, rather
than at debonding (Marini 1999; Robertson 2011;
Sköld-Larsson 2013).
• Outcomes assessed some weeks after debonding (Alexander
2000; Boyd 1992; Boyd 1993).
• Abstracts with insufficient information for inclusion and no
response from authors (Alwi 1994; Neumann 1976; Salzmann
1976).
• DMFS/DMFT (decayed, missing and filled surfaces/teeth)
outcome measures, not DWLs (D’Agostino 1988; Dénes 1988;
Dénes 1989; Dénes 1991).
• Fluoride intervention confounded (Øgaard 1997; Øgaard
2001; Ullsfoss 1994).
Risk of bias in included studies
Overall risk of bias assessments for all included studies are shown
in Figure 1. One study (Stecksén-Blicks 2007) was assessed at low
risk of bias for all domains, for another study (Øgaard 2006) the
overall risk of bias was unclear and the remaining included study
(Luther 2005) was assessed at high risk of bias.
Allocation
Two of the included studies clearly reported the method of se-
quence generation and clear allocation concealment and were as-
sessed at low risk of selection bias (Luther 2005; Stecksen-Blicks
2007).
One study (Øgaard 2006) reported the method of sequence gen-
eration (randomisation table) but did not mention allocation con-
cealment. This study was assessed at unclear risk of selection bias.
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Blinding
Two studies were considered truly triple-blind (participant, clin-
ician and assessor) (Øgaard 2006; Stecksén-Blicks 2007) because
placebos and comparison interventions were identical in appear-
ance to the experimental intervention.
In Luther 2005, participants and clinicians were not blinded, and
the resulting risk of performance bias was high; outcome assessors,
however, were blinded, so the risk of detection bias was assessed
as low.
Incomplete outcome data
Few postrandomisation exclusions were reported in Stecksén-
Blicks 2007 and Øgaard 2006, and numbers and reasons for ex-
clusion were similar for each group; therefore, the risk of attrition
bias was assessed as low. In Luther 2005, the overall rate of pos-
trandomisation exclusions was very high, so this study was assessed
at high risk of attrition bias.
Selective reporting
Both Stecksén-Blicks 2007 and Øgaard 2006 reported all planned
outcomes in full and were assessed at low risk of reporting bias.
In the report of the study by Luther 2005, some information was
missing and the denominators were not stated, so this study was
assessed at unclear risk of reporting bias.
Other potential sources of bias
In two studies (Øgaard 2006; Stecksén-Blicks 2007), no other
sources of bias were identified. Luther 2005 was assessed at unclear
risk of other bias because of possible differences between the groups
in terms of compliance, duration of orthodontic treatment and
exposure to topical fluorides.
Effects of interventions
See: Summary of findings for the main comparison Fluoride
varnish versus placebo varnish
Topical fluorides
The three studies included in this review evaluated differentmodes
of application of topical fluorides.
• Fluoride-containing varnish versus non-fluoride-containing
placebo varnish (Stecksén-Blicks 2007).
• Amine fluoride and stannous fluoride toothpaste/
mouthrinse combination versus sodium fluoride toothpaste/
mouthrinse combination (Øgaard 2006).
• Intraoral fluoride-releasing glass bead device versus fluoride
mouthrinse (Luther 2005).
Fluoride varnish/paste versus placebo
The trial by Stecksén-Blicks 2007 compared applicationof fluoride
varnish (Fluor Protector containing 0.1% fluoride (F) as difluo-
rosilane in a polyurethane varnish base, Ivoclar Vivadent) every six
weeks versus a non-fluoride-containing placebo varnish, in a dou-
ble-blind study assessed as being at low risk of bias. The outcome
was new demineralised white lesions (DWLs) identified from clin-
ical photographs taken before and after orthodontic treatment. A
reduction of DWLs (almost 70%) was associated with regular ap-
plication of fluoride varnish during orthodontic treatment in this
study (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.21 to
0.44; Analysis 1.1). No adverse effects were reported. The study
result should be interpreted cautiously until further clinical trials
confirm this finding.
Different types of fluoride administered in toothpaste and
mouthrinse
Øgaard 2006 compared two different types of fluoride compounds
provided as toothpaste (twice daily) and mouthrinse (once daily)
and supplied to participants for use during orthodontic treatment.
One group received amine fluoride/stannous fluoride toothpaste
(Meridol 140 parts per million (ppm) F, pH 4.5) and amine fluo-
ride/stannous fluoride mouthrinse to be used after toothbrushing
at bedtime (250 ppm F, pH 4.0). The other group received neutral
sodium fluoride toothpaste (1400 ppm, pH 6.7) and a sodium
fluoride mouthrinse (250 ppm F, pH 6.3) to be used after brush-
ing at bedtime.
The outcome of newDWLswas reported at the tooth level with no
indication of correction for clustering of teeth within the mouth.
The mean change in the white spot lesion index from baseline
was greater in the sodium fluoride group, suggesting that this
compound was less effective than amine fluoride/stannous fluo-
ride (Analysis 2.1). A slightly larger increase in both the visible
plaque index and the gingival bleeding index was reported over
the duration of treatment in the group exposed to sodium fluoride
(Analysis 2.2; Analysis 2.3). However, these differences should be
interpreted cautiously until the results can be independently repli-
cated.
Fluoride-releasing intraoral device
In the study by Luther and colleagues (Luther 2005), the exper-
imental group received a carbonate-based glass bead containing
13.3% fluoride glass (Telsol (UK) Ltd), which was attached to the
orthodontic brace. The control group was requested to use a daily
fluoride mouthrinse (Endekay rinse 0.05% w/v NaF, Stafford-
Miller Ltd). The number and size of new DWLs were determined
using computerised image analysis of before and after cross-po-
larised (to reduce flash reflections) photographic images of six an-
terior teeth in each participant. Results were available for only 37
participants of the original 70 recruited (53%) (Analysis 3.1). The
glass beads proved to be fragile, and 18 breakages were reported.
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Secondary outcomes
None of the three included studies reported data for the secondary
outcomes of this review: any differences in size and severity of
DWLs, quantitative assessment of enamelmineral loss, participant
perception ofDWLs and anymeasure of oral health-related quality
of life, and adverse effects.
Sensitivity analyses
Insufficient trials were included in the review for a sensitivity anal-
ysis to be undertaken.
Publication bias
Insufficient trials were included in this review to enable the review
authors to investigate publication bias.
D I S C U S S I O N
Summary of main results
Moderate-quality evidence from one trial at low risk of bias indi-
cates that fluoride varnish applied every sixweeks is associatedwith
a reduction innewdemineralisedwhite lesions (DWLs) (Summary
of findings for the main comparison).
Evidence is insufficient to show whether amine fluoride and stan-
nous fluoride toothpaste/mouthrinse combination is more or less
effective than sodium fluoride toothpaste/mouthrinse combina-
tion in preventing DWLs, visible plaque or gingivitis.
Evidence is also insufficient to show whether a reduction in the
development of DWLs occurs with the use of an intraoral fluoride-
releasing glass bead device.
Overall completeness and applicability of
evidence
The latest update of the review has included only parallel-group
trials, in which the individual participant is the unit of randomisa-
tion.Thiswas decideduponbecause of the possibility of cross-con-
tamination between experimental and control teeth in the same
mouth, either between upper and lower arches or between sides
of the mouth, which might lead to under-estimation of the effec-
tiveness of any fluoride products.
Interventions that rely on the patient for delivery, including flu-
oride mouthrinse and toothpaste, will work only if they are used
regularly. They rely greatly on patient compliance to succeed; how-
ever, evidence suggests that compliance with mouthrinsing is poor
among orthodontic patients. One study (Geiger 1992) found that
only 42%of participants rinsedwith a sodiumfluoridemouthrinse
at least every other day. Results also showed that those who com-
plied least with fluoride rinsing regimens tended to have more
DWLs. It is important to consider the acceptability of interven-
tions to both adolescents and adults with a view toward increasing
compliance with recommended dental hygiene practices.
Interventions that are professionally applied and deliver fluoride
’passively’, such as fluoride varnish, fluoride-releasing bracket ce-
ments and fluoride-releasing elastics, avoid the need for patient
compliance. In addition, these materials deliver fluoride close to
the bracket, where it is most needed; however, many fluoridated
materials release large amounts of fluoride initially, but the level
drops rapidly andmight not be sufficient to prevent decay over the
whole course of orthodontic treatment. Reapplication of fluoride
varnish and frequent replacement of fluoride-releasing elastics are
likely to be required. In the parallel-group trial of a fluoride varnish
intervention included in this review, varnish was reapplied every
six weeks at each orthodontic check-up appointment. We found
no parallel-group trials of fluoride-releasing cements or elastics
that met the inclusion criteria for this review.
An interesting addition, since the initial review was carried out,
is the further development of materials that produce a slow and
sustained release of fluoride (Luther 2005). This trial was small
and at high risk of bias, and evidence was insufficient to reveal
whether these devices are more or less effective than a mouthrinse
in reducing the development of DWLs. It is possible, that with
further refinement, this technique could potentially be effective.
Intraoral fluoride-releasing devices should be evaluated by double-
blind parallel-group randomised controlled trials.
When examining the effectiveness of a fluoride product in prevent-
ingdental decay, one should consider two aspects: first, whether the
fluoride product reduces the number of DWLs appearing during
treatment, and second, whether it reduces the severity of DWLs in
terms of the size or area of the tooth surface affected, the amount
of mineral lost or the depth of decay. Banks et al (Banks 2000)
developed the Enamel Decalcification Index, which is an ordinal
index that includes an assessment of the area covered. Assessment
of the size of the lesion is a useful outcome measure, but none of
the studies included in this review reported this outcome.
Ideally the appearance of the tooth should be recorded before and
after orthodontic treatment, so that the change in appearance of
the tooth is measured (incidence), not just its appearance at the
end (prevalence). There are many different causes of white lesions
on the teeth, many of which occur during the development of the
teeth. It is important that these development lesions, as well as de-
cay that has occurred before the brace is fitted, are excluded from
the analysis, hence the need for the images (photographs or fluo-
rescent) taken before treatment. Measurement of both incidence
and severity will depend on the method used to record DWLs.
Two main methods may be used: visual inspection and clinical
images. Both methods are associated with problems. One problem
with visual inspection is that the examiner or examiners will re-
quire calibration at the start and regular recalibration throughout
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the experimental period to ensure consistency of measurement.
The duration of the experiment might be quite long because, as
discussed later, the product should ideally be tested over the entire
length of orthodontic treatment. This can take between 18 and 30
months - sometimes longer. Another problem with visual record-
ing involves masking of the assessor to the allocated intervention.
To reduce bias, the examiner should not know whether the par-
ticipant has received a fluoride product and this will complicate
the way the experiment is run.
Images have the advantage of providing a permanent record of
the appearance of the tooth. Assessments can be carried out by
several people independently or in groups, whereby a consensus
is achieved. The images can be placed in a random order and the
judges masked to group allocation. In addition, because the assess-
ment can be performed over a short period of time the problem
of examiner drift, whereby an assessor might subtly change his
or her assessment over time, is reduced. The challenge of using
clinical photographs consists of achieving consistency in lighting
and reducing reflections that can mask or mimic DWLs; however,
when a careful photographic technique is applied, the advantages
of photographs outweigh their potential disadvantages. Several op-
tical and fluorescent methods are available for measuring lesions
on the teeth (Angmar-Mansson 1996). These methods require
specialised equipment, which would add considerably to the cost
of a clinical study, but they provide an objective measurement of
the amount of decay in terms of mineral loss or lesion depth or
both.
Quality of the evidence
It is important to note that only one study included in this re-
view was judged to be at low risk of bias, and this assessment was
made only after contact with the author resulted in clarification of
two issues. Both the design and the reporting of trials of fluorides
for preventing DWLs were generally poor, even in the most re-
cent trials published in journals for which the use of CONSORT
guidelines has been adopted. In particular, themethods of random
allocation, sequence generation and concealment were rarely ex-
plained. Few studies provided a flow diagram to show withdrawals
and drop-outs.
Potential biases in the review process
We undertook a sensitive search of several electronic sources, sup-
plemented by searches of references lists. We placed no restric-
tion on language or publication status. The review authors have
tried, as far as possible, to identify all possible studies that might
meet the inclusion criteria for this review. Study authors have been
contacted, and many have replied; however, some were not able
to supply the requested information, as their records have been
destroyed or lost.
When a product, such as a bonding material, can be applied to
single teeth, it is tempting to use an experimental design whereby
the material being tested is used in two quadrants of the mouth
and the control material is used in the other two quadrants. This
is called a split-mouth design. The main advantage of the split-
mouth design over a conventional parallel-group study design, in
which the two materials are tested in two separate groups of in-
dividuals, is that the experimental material is tested in the same
mouth, under the same conditions as the control material. In the-
ory, any differences in outcome between the two materials are due
only to their properties - not to other factors, such as differences in
oral hygiene and diet between participants (with a parallel design)
or even differences in oral hygiene and diet over time within the
same participants (with a cross-over design).
Unfortunately, when one is examining the ability of fluoride prod-
ucts to reduce decay, it is highly unlikely that the fluoride released
will be confined to only the quadrants/teeth in which the experi-
mental material has been placed, and some contamination of the
’untreated’ teeth is inevitable. This contamination will reduce the
difference in outcomes between treated and untreated teeth. The
previous versionof this review included split-mouth studies, which
failed to show any difference between treated and untreated teeth;
this may be due to cross-over contamination between control and
experimental sides and may reflect our contention of contamina-
tion. For this reason, we have decided to exclude split-mouth stud-
ies from this update of our review, and we recognise that changes
to the protocol introduce a risk of bias to the review process.
Agreements and disagreements with other
studies or reviews
Three other systematic reviews gathering evidence for the most
effective means of preventing caries/demineralisation during fixed
orthodontic appliance treatment have been reported in the litera-
ture. Derks et al (Derks 2004) examined all preventive measures
for preventing demineralisation - not just fluoride products. These
review authors had to exclude many published studies as well be-
cause of inappropriate research design or poor reporting and were
unable to provide firm, evidence-based recommendations as to the
prevention of DWLs during fixed orthodontic treatment.
A second systematic review (Chadwick 2005) investigated the ef-
fectiveness of topical fluorides used alone in preventing deminer-
alisation during orthodontic treatment. These review authors in-
cluded seven studies in their review; however, these studies were
excluded from our review because the outcomes were not appro-
priate (DMFT/DMFS), or the participants were not examined
immediately after removal of the fixed appliance(s). Although they
suggest that according to their outcome measure (preventive frac-
tion), some evidence shows that the addition of a topical fluoride
preparation helps in the prevention of demineralisation during
fixed orthodontic treatment, this conclusion must be viewed with
caution, because these review authors were not able to calculate
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confidence intervals. We support their request that researchers de-
sign and report their studies using standard outcomes, so that in
the future, data may be pooled and overall recommendations on
preventive measures may be provided.
Rogers et al (Rogers 2010) included 10 studies in their systematic
review investigating the effectiveness of fluoride-containing bond-
ing adhesives used in orthodontics to prevent demineralisation.
Five of these studies were excluded from our review because they
were not randomised, and a further three studies were excluded
because data in the report were insufficient, and the study authors,
when contacted, were unable to provide requested data. Rogers’
conclusions are consistent with ours with regard to the design of
trials and the quality of reporting and statistical analyses.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Moderate quality-evidence from one well-designed clinical trial
suggests that six-weekly, professional application of a varnish con-
taining a high concentration of fluoride reduces the incidence
of demineralised white lesions (DWLs) during orthodontic treat-
ment; however, further well-designed studies are required to con-
firm this finding.
Evidence is insufficient for review authors to recommend the use of
intraoral fluoride-releasing devices. Such interventions, provided
they sustain the release of fluoride, have the potential to be ef-
fective, as they reduce the requirement for patient compliance.
Fluoride mouthrinses, in addition to fluoride toothpastes, have
been found to be effective in reducing caries in non-orthodontic
patients, but no direct evidence from this review indicates that
these interventions are effective in patients with fixed orthodontic
appliances. It is likely that fluorides that do not require patient
compliance will be more effective in preventing DWLs.
Implications for research
More evidence is required before the most effective way of deliv-
ering fluoride to the orthodontic patient can be determined. In
particular, fluoride delivery methods that do not require patient
compliance should be studied. Adequately powered, double-blind,
placebo-controlled trials, with appropriate randomisation, alloca-
tion concealment andmasking of outcome assessment, are needed.
However, a placebo-only group may be considered unethical. The
use of factorial designs, whereby two or more experimental inter-
ventions are evaluated simultaneously allowing for the evaluation
of possible interaction between the interventions, can be evaluated
separately. Researchers should, however, be aware that increasing
the number of arms in a trial will substantially increase the num-
ber of participants required to demonstrate a statistical difference
between interventions.
Another weakness of many studies was that they were undertaken
over a relatively short period of orthodontic treatment. Short-term
studies tend to overestimate the effectiveness of an intervention,
particularly if it is a fluoride product, which releases high levels of
fluoride initially, or if the intervention requires sustained patient
co-operation. The effectiveness of products over the full duration
of orthodontic treatment should be assessed. The influence of
confounders, such as diet, fluoridated water supplies and age of
the participant, as well as other outcomes, including participant-
reported data, should be included in trial designs.
The use of images to record the condition of the tooth before and
after treatment should be encouraged. Images provide a permanent
record, allowing before and after comparisons of the incidence and
severity of DWLs with proper assessor blinding, error analysis and
consensus measures. To provide a reproducible method of record-
ing DWLs using photographs, a standard technique is required,
with thought given to reduction of flash reflection, magnification
and drying of the teeth. Optical and fluorescent methods of pro-
viding a quantitative measurement of mineral loss should be en-
couraged if funding allows. Studies ideally should assess partici-
pant-centred outcomes, including the effect of DWLs on quality
of life, particularly six months or a year after treatment.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Luther 2005
Methods Trial design: 2-arm parallel-group RCT
Unit of randomisation: Participants
Location: Leeds, UK
Number of centres: 1
Recruitment period: December 1998 to December 1999
Funding source: BDA Research Foundation Shirley Glasstone Hughes Memorial Prize
Fund and the Listerine Preventive Care Award
Participants Inclusion criteria: Participants with upper incisors and canines developing and at least 3
upper permanent incisors and 1 upper permanent canine erupted, prior to commence-
ment of orthodontic treatment with fixed upper appliances
40 F/28 M (sic)
Exclusion criteria: Participants with grossly damaged, restored or defective upper per-
manent canines or incisors, participants living in areas with fluoridated water supply,
physically or mentally handicapped individuals, those with comorbidities or requiring
antibiotic cover and pregnant or nursing females
Mean age at baseline, years: 15.7 (range 11 to 45)
Number randomised: 70 (34 F-releasing glass bead and 36 F rinse)
Number evaluated: 37 (18 F-releasing glass bead and 19 F rinse)
Interventions Comparison: Fluoride-releasing glass beads versus fluoride rinse
Group A (n = 18): Fluoride-releasing glass bead (containing 13.3% F) attached to ap-
pliance
Group B (n = 19): Fluoride rinse (Endekay 0.05% NaF). Participants instructed to use
5 drops in 10 ml of water and to rinse once daily
Duration of treatment: Approximately 19 months (recruitment ended December 1999;
final data collection September 2002)
Outcomes Before and after cross-polarised images of 6 upper anterior teeth, assessed by a masked
individual using image analysis, salivary fluoride levels
Notes Background exposure to fluoride not reported: Unclear whether participants used fluo-
ride toothpaste
Power calculation reported that 28 participants/group would be needed to show the
expected 75% difference; it was planned to recruit 35 per group to allow for drop-outs
Large numbers of participants both withdrawing or dropping out (total 14: 6 control,
8 experimental), as well as insufficient data for analysis (total 19: 11 control, 8 experi-
mental). Null findings should be interpreted with caution, as investigators lost so many
in their sample, which means that it is likely that this study lacks statistical power
Risk of bias
Bias Authors’ judgement Support for judgement
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Luther 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “A random number table was gen-
erated on an Excel spreadsheet by the trial’s
statistical advisor”
Allocation concealment (selection bias) Low risk Quote: “Each time a patient agreed to take
part in the study, a dental nurse who was
not involved in the running of the study
accessed the concealed table and crossed off
the next number, informing the operator
of the treatment to be used i.e. whether the
patient had been allocated to the fluoride
rinse or FGB group”
Blinding - Patients & Operators High risk Not possible to blind participants or oper-
ators to allocated intervention
Blinding - Outcome assessors Low risk Quote: “Analysis was undertaken blind by
one operator, who was unaware of which
group the teeth being analysed came from”
Incomplete outcome data addressed High risk 14 participants (8 F-releasing glass bead
and 6 rinse) dropped out - reasons not
given. Further 19 (8 F-releasing glass bead
and 11 rinse) excluded from analysis be-
cause of insufficient data, and reasons not
explained. 47% of randomised participants
not included in the analysis. High rate of
breakage of F-releasing glass beads. Sub-
stantial risk of bias due to attrition
Free of selective reporting Unclear risk Numbers of participants and teeth with
DWLs reported at the beginning and at the
end of the trial, but denominators were un-
clear. No indication of mean size of lesions
in each group. Salivary fluoride levels not
reported
Free of other bias Unclear risk Number of breakages of F-releasing glass
beads reported, but no indication of level
of compliance in fluoride rinse group. No
information on duration of trial and there-
fore durationof exposure tofluoride in each
group
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Stecksén-Blicks 2007
Methods Trial design: Parallel RCT
Unit of randomisation: Individuals
Location: Skelleftea & Lycksele, Sweden
Number of centres: 2
Recruitment period: Not stated
Funding source: Grants from the County Council of Vasterbotten & Swedish Dental
Society, with varnishes supplied by Ivoclar Vivadent and brackets by 3M Unitek
Participants Inclusion criteria: Children 12 to 15 years of age scheduled for maxillary treatment with
fixed orthodontic appliances for an expected duration of at least 6 months
Exclusion criteria: None stated
Mean age at baseline, years: 14.3 ± 1.6
Number randomised: 273 (137 and 136)
Number evaluated: 257 (132 and 125)
Interventions Comparison: Fluoride varnish (Fluor Protector) versus placebo
Group A (n = 137): Fluor Protector (0.1% F difluorosilane in polyurethane base) varnish
applied after bonding and at each checkup (approximately every 6weeks) until debonding
Group B (n = 136): Placebo varnish, identical in appearance to active, applied after
bonding and at the end of each check-up (every 6 weeks) until debonding
In both groups, after removal of visible plaque with an explorer, 0.2 to 0.3 ml varnish
was applied around the bracket bases in a thin layer with a minibrush and was allowed
to dry for 2 minutes. Participants were instructed to avoid all eating and drinking for 2
hours and to not brush teeth until the following day
Duration of treatment: Not given, but mean number of applications of varnish was 10,
and assuming they were seen every 6 weeks, the mean duration was 60 weeks or just over
1 year (which is quite short)
All children strongly advised to brush teeth with 1000 to 1500 ppm fluoride toothpaste
at least twice daily
Fluoride in piped drinking water in these communities was < 0.2 ppm
Outcomes Before and after clinical photographs assessed for presence and severity of DWLs by 2
experienced and calibrated judges
Notes Sample size calculation reported. Estimated requirement for 132 participants per group
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote (author): “The patients were as-
signed to one of the two groups on the basis
of odd and even numbers from a dice”
Comment: The corresponding author was
asked how investigators obtained equal
numbers in all groups but does not seem to
have answered this
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Stecksén-Blicks 2007 (Continued)
Allocation concealment (selection bias) Low risk Quote (author): “The study was coordi-
nated from the Department of Paediatric
Dentistry and the randomization was per-
formed there by an independent technician
not involved in the clinical work and col-
lection of data”
Blinding - Patients & Operators Low risk Quote (author): “The placebo varnish ap-
plied had an identical composition but
without fluoride. Both varnishes were un-
coloured and obtained from the producer
in identical bottles coded by colour. Nei-
ther clinicians nor patients knew whether
they were treated with fluoride or placebo
varnish”
Comment: The study was double-blind
Blinding - Outcome assessors Low risk Quote: The two “experienced and cali-
brated” judges who scored the photographs
for presence/absence and severity of DWLs
“were not involved in the treatment of the
patients and blinded for group assignment”
Incomplete outcome data addressed Low risk Comment: Flow diagram provided and
withdrawals and drop-outs reported (5/
137 or 4% experimental; 11/136 or 8%
controls). Reasons given and similar in each
group. Unlikely to have introduced a bias
Free of selective reporting Low risk Planned outcome was white spot lesions at
debonding in each group. Reported as %
prevalence with P value for difference be-
tween groups. No apparent evidence of se-
lective reporting
Free of other bias Low risk No other sources of bias identified
Øgaard 2006
Methods Trial design: 2-arm double-blind parallel-group RCT
Unit of randomisation: Individual
Location: Sweden
Number of centres: 2
Recruitment period: Starting orthodontic treatment in1999
Funding source: The study was supported by GABA International, Basel, Switzerland
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Øgaard 2006 (Continued)
Participants Inclusion criteria: Participants were those starting orthodontic treatment in 1999 with
fixed appliances in both arches
Exclusion criteria: None stated
Age at baseline: Not stated
Number randomised: 115
Number evaluated: 97
Interventions Comparison: 2 different fluoride toothpastes and mouthrinses
Group A (n = 50): Participants were instructed to brush twice daily with toothpaste
containing amine fluoride and stannous fluoride combination (AmF/SnF2 140 ppm,
pH 4.5) and to rinse every evening after toothbrushing with a solution containing amine
fluoride and stannous fluoride
Group B (n = 47): Participants were instructed to brush twice daily with toothpaste
containing neutral sodium fluoride (NaF 1400 ppm, pH 6.7) and to rinse every evening
after toothbrushing with a solution containing NaF (250 ppm, pH 6.3)
Duration of treatment: Fluoride treatments were continued for the whole duration of
orthodontic treatment with fixed appliances
Outcomes White spot lesion index, visible plaque index, gingival bleeding index, measured at
baseline and at debonding
Notes Background exposure to fluoride: Not reported
Power calculation: Not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “allocated to two groups at bonding
according to a randomized table”
Comment: Assumed this refers to random
number table
Allocation concealment (selection bias) Unclear risk Not described
Comment: Assumed not done
Blinding - Patients & Operators Low risk Double-blind. Quote: “Neither the sub-
jects nor the research team were informed
about which group each participant be-
longed to”
Blinding - Outcome assessors Low risk Double-blind. Quote: “Neither the sub-
jects nor the research team were informed
about which group each participant be-
longed to”
Incomplete outcome data addressed Low risk 18 of the patients invited to participate
were not included in the evaluation. Not
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Øgaard 2006 (Continued)
stated which groups they were from, but
it seems likely that number was similar
in each group. Reason given was moving
house
Free of selective reporting Low risk Planned outcomes reported in full
Free of other bias Low risk No other sources of bias identified
DWL = demineralised white lesion; F = fluoride; ppm = parts per million; RCT = randomised controlled trial.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alexander 2000 Clinical assessment carried out 1 month after debonding not immediately after
Alwi 1994 Abstract only. Insufficient information to include in review. Contacted author. Unable to provide sufficient
data for analysis. No subsequent publication identified
Banks 1997 Split-mouth study
Banks 2000 CCT with alternate allocation to fluoride or non-fluoride elastomeric ligatures
Blanco 1988 “Patients chosen at random” and divided into 2 groups. Report is unclear about the details of allocation
to each group, groups are unequal in size, no baseline characteristics, and no outcome data presented per
participant. Unable to contact authors and unable to include this study based on available information
Boyd 1992 Demineralisation assessed 3 months after debonding rather than immediately
Boyd 1993 Demineralisation assessed 3 months after debonding rather than immediately
Boyles 2007 Not RCT
Buyukyilmaz 1994 Split-mouth study
Chung 1998 Split-mouth study
Czochrowska 1998 Split-mouth study
D’Agostino 1988 Outcomes were DMFT and DMFS not demineralised white lesions
Demito 2011 Split-mouth study
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(Continued)
Dyer 1982 Not RCT
Dénes 1988 Assessed DMFS not white spot lesions
Dénes 1989 Assessed DMFS not white spot lesions
Dénes 1991 Assessed DMFS not white spot lesions
Farhadian 2008 Not RCT
Fricker 1985 Not RCT
Fricker 1987 Not RCT
Gaworski 1999 Not RCT
Geiger 1988 Not RCT
Geiger 1992 Not RCT
Gillgrass 2001 Split-mouth study
Gorton 2003 Ex vivo study - outcomes measured on extracted teeth
Hirschfield 1978 Not RCT
Leizer 2010 Appears to be allocation based on study number (odd or even) and teeth allocated alternately. CCT. No
reply to emails sent to contact author
Maijer 1988 Not RCT
Marcusson 1997 Split-mouth study
Marini 1999 Duration of intervention 12 months but outcomes assessed at end of treatment period not at the end of
treatment with fixed orthodontic appliances
Mattick 2001 Split-mouth RCT
Millett 1999 Split-mouth study, allocation of each side to treatment by alternation. Not RCT
Millett 2000 Split-mouth study, allocation of each side to treatment by alternation.Not RCT
Mitchell 1992 Split-mouth study, no random allocation. Author contacted
Neumann 1976 Abstract only. Insufficient data, no subsequent publication identified
O’Reilly 1987 Ex vivo study - outcomes measured on extracted teeth
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(Continued)
Pascotto 2004 Ex vivo study - outcomes measured on extracted teeth
Robertson 2011 Duration of intervention 12 months but outcomes assessed at end of treatment period not at the end of
treatment with fixed orthodontic appliances
Salzmann 1976 Abstract only. No subsequent publication identified
Shan 2008 Split-mouth study
Shannon 1978 Allocation method not stated. Unable to contact the authors
Shannon 1979 Allocation method not stated. Unable to contact the authors
Sköld-Larsson 2013 Intervention period was short (12 weeks) and assessments were not undertaken at the start and end of
orthodontic treatment
Sonis 1989 Not RCT
Trimpeneers 1996 Split-mouth study. All participants had the same product used in the same quadrants. Not RCT.Contacted
author (LR Dermaut). Unable to provide further data for statistical analysis
Turner 1993 Split-mouth study
Twetman 1997 Split-mouth study
Ullsfoss 1994 Both groups had fluoride mouthrinse. The experimental group had in addition an antimicrobial
mouthrinse, therefore the study looks at the efficacy of the antimicrobial mouthrinse rather than the flu-
oride mouthrinse
Underwood 1989 Random allocation not mentioned. Brackets on alternate teeth bonded with each adhesive. Not RCT
van der Linden 1998 Split-mouth study
Vivaldi-Rodrigues 2006 Split-mouth study
Wenderoth 1999 Not RCT
Øgaard 1986 Ex vivo study - outcomes measured on extracted teeth
Øgaard 1992 Random allocation to treatment not mentioned. Author contacted
Øgaard 1996 Not RCT. Author contacted
Øgaard 1997 Effect of fluoride confounded by co-intervention. Both groups had fluoride varnish. The experimental
group had in addition an antimicrobial varnish therefore the study looks at the efficacy of the antimicrobial
varnish rather than the fluoride varnish
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Øgaard 2001 Effect of fluoride confounded by co-intervention. 2 randomised groups and 1 non-randomised control
group. Both randomised groups received fluoride varnish every 12 weeks, fluoride exposure was not
different between the 2 randomised groups
CCT = controlled clinical trial; DMFS/DMFT = decayed, missing and filled surfaces/teeth.
Characteristics of ongoing studies [ordered by study ID]
NCT00268138
Trial name or title Phase 4 study on prevention of incipient carious lesions (white spot lesions) in patients with fixed orthodontic
appliances following the application of Elmex gel
Methods Parallel-group, double-blind RCT
Participants 314 healthy participants between 10 and 60 years of age, undergoing orthodontic treatment
Interventions Toothbrushing with Elmex gel or placebo product once weekly during the entire study (12 to 30 months)
plus tray application of test or control product 4 times per year
Outcomes Visually detected white spot lesions
Starting date April 2006
Contact information Principal Investigators Dr Meir Radlich (mredlich@zahav.net.il) and Prof Paul George Jost-Brinkman (paul-
g.jost-brinkmann@charite.de)
Notes Email sent to Jost-Brinkmann to request results 19/7/2012. Email reply 19/7/2012 stating that last participant
now finished and data analysis about to start
NCT01768390
Trial name or title Caries-preventive effectiveness of a dentifrice containing 5000 ppm fluoride - a randomised controlled trial
in adolescents with fixed orthodontic appliances
Methods Parallel-group single-blind RCT
Participants 420 healthy participants 11 to 16 years old, undergoing orthodontic treatment
Interventions High-dose (5000 ppm) fluoride toothpaste versus usual-dose (1450 ppm) fluoride toothpaste
Outcomes Incidence and severity of white spot lesions over the duration of orthodontic treatment (18 to 24 months)
Starting date January 2008. Data collection expected to be complete July 2012
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NCT01768390 (Continued)
Contact information Professor SHA Twetman, University of Copenhagen (stw@odont.ku.dk )
Notes Email sent to Prof Twetman 24 June 2013. Reply 25 June 2013: “The study is completed and the manuscript
was submitted for publication about one month ago. We have not yet received any response from the journal
but if we are lucky, it will appear ”on line“ later this year.” Abstract presented at European Orthodontic
Society meeting, Reykjvik, Iceland, June 2013
NCT01925924
Trial name or title Resin-modified glass ionomer or composite for orthodontic bonding? A multicentre, randomised, single-
blinded clinical trial
Methods A multicentre randomised single-blinded controlled clinical trial with 2 parallel groups
Participants 206 orthodontic patients requiring upper and/or lower preadjusted edgewise fixed appliance therapy, 11 years
of age or older
Interventions Brackets will be bonded to all teeth in front of the first permanent molars with either a resin-modified glass
ionomer cement (Fuji Ortho LC) or a light cured composite control (Transbond)
Outcomes Primary: Incidence and severity of demineralisation at the end of treatment. Secondary: Incidence of first
time bond failures
Starting date February 2009
Contact information Dr Philip Benson, University of Sheffield (p.benson@sheffield.ac.uk)
Notes
ppm = parts per million; RCT = randomised controlled trial.
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D A T A A N D A N A L Y S E S
Comparison 1. Fluoride varnish versus placebo varnish
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of participants with
new DWLs
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 2. Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus sodium fluoride
toothpaste/mouthrinse combination
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 White spot index 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2 Visible plaque index 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Gingival bleeding index 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Comparison 3. Intraoral fluoride-releasing glass bead device versus mouthrinse-only control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of participants with
new DWLs
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Fluoride-releasing
intraoral device versus fluoride
mouthrinse
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Fluoride varnish versus placebo varnish, Outcome 1 Number of participants
with new DWLs.
Review: Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Comparison: 1 Fluoride varnish versus placebo varnish
Outcome: 1 Number of participants with new DWLs
Study or subgroup Favours F varnish
Favours
non-F
varnish Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stecks n-Blicks 2007 26/132 80/125 0.31 [ 0.21, 0.44 ]
Subtotal (95% CI) 0 0 0.0 [ 0.0, 0.0 ]
Total events: 26 (Favours F varnish), 80 (Favours non-F varnish)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
0.1 0.2 0.5 1 2 5 10
Favours F varnish Favours control
Analysis 2.1. Comparison 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus
sodium fluoride toothpaste/mouthrinse combination, Outcome 1 White spot index.
Review: Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Comparison: 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus sodium fluoride toothpaste/mouthrinse combination
Outcome: 1 White spot index
Study or subgroup AmF/SnF2 NaF
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
gaard 2006 50 0.03 (0.11) 47 0.08 (0.16) -0.05 [ -0.10, 0.00 ]
-1 -0.5 0 0.5 1
Favours AmF/SnF2 Favours NaF
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Analysis 2.2. Comparison 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus
sodium fluoride toothpaste/mouthrinse combination, Outcome 2 Visible plaque index.
Review: Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Comparison: 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus sodium fluoride toothpaste/mouthrinse combination
Outcome: 2 Visible plaque index
Study or subgroup AmF/SnF2 NaF
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
gaard 2006 50 0.02 (0.21) 47 0.11 (0.22) -0.09 [ -0.18, 0.00 ]
-1 -0.5 0 0.5 1
Favours AmF/SnF2 Favours NaF
Analysis 2.3. Comparison 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus
sodium fluoride toothpaste/mouthrinse combination, Outcome 3 Gingival bleeding index.
Review: Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Comparison: 2 Amine fluoride/stannous fluoride toothpaste/mouthrinse combination versus sodium fluoride toothpaste/mouthrinse combination
Outcome: 3 Gingival bleeding index
Study or subgroup AmF/SnF2 NaF
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
gaard 2006 50 0.03 (0.22) 47 0.1 (0.18) -0.07 [ -0.15, 0.01 ]
-1 -0.5 0 0.5 1
Favours AmF/SnF2 Favours NaF
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Analysis 3.1. Comparison 3 Intraoral fluoride-releasing glass bead device versus mouthrinse-only control,
Outcome 1 Number of participants with new DWLs.
Review: Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment
Comparison: 3 Intraoral fluoride-releasing glass bead device versus mouthrinse-only control
Outcome: 1 Number of participants with new DWLs
Study or subgroup Intraoral F device Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Fluoride-releasing intraoral device versus fluoride mouthrinse
Luther 2005 8/18 6/19 1.41 [ 0.61, 3.26 ]
0.02 0.1 1 10 50
Favours intraoral device Favours control
A P P E N D I C E S
Appendix 1. Cochrane Oral Health Group’s Trials Register search strategy
(orthodontic* AND (cariostatic* OR fluoride* OR naf OR “glass ionomer*” OR “cermet cement*” OR compomer* OR “composite
resin*”) AND (“dental enamel solubility” OR caries OR “dental fissures” OR demineriali* OR reminerali* OR decalcifi* OR “white
spot*” or lesion*))
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
#1 MeSH descriptor Orthodontics explode all trees
#2 orthodontic*
#3 (#1 OR #2)
#4 MeSH descriptor Sodium Fluoride explode all trees
#5 MeSH descriptor Fluorides, Topical explode all trees
#6 fluoride*
#7 topical next fluoride*
#8 NaF
#9 MeSH descriptor Glass Ionomer Cements, this term only
#10 glass next ionomer*
#11 (#4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10)
#12 MeSH descriptor Dental Enamel Solubility explode all trees
#13 MeSH descriptor Tooth Demineralization explode all trees
#14 reminerali* or deminerali* or decalcif*
#15 white next spot*
#16 (#12 OR #13 OR #14 OR #15)
#17 (#3 AND #11 AND #16)
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Appendix 3. MEDLINE (OVID) search strategy
1. exp ORTHODONTICS/
2. orthodontic$.mp.
3. 1or 2
4. exp SODIUM FLUORIDE/
5. exp FLUORIDES TOPICAL/
6. fluoride$.mp.
7. NaF.ti,ab.
8. Glass Ionomer Cements/
9. (glass adj ionomer$).mp.
10. or/4-9
11. exp DENTAL ENAMEL SOLUBILITY/
12. TOOTH DEMINERALIZATION/
13. (reminerali$ or deminerali$ or decalcif$).mp.
14. ((white adj spot$) or lesion$).mp.
15. 11 or 12 or 13 or 14
16. 3 and 10 and 15
The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in
MEDLINE: sensitivity maximising version (2008 revision), as referenced in Chapter 6.4.11.1 and detailed in Box 6.4.c of theCochrane
Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011].
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
Appendix 4. EMBASE (OVID) search strategy
1. exp ORTHODONTICS/
2. orthodontic$.mp.
3. 1 or 2
4. exp SODIUM FLUORIDE/
5. exp FLUORIDES TOPICAL/
6. fluoride$.mp.
7. NaF.ti,ab.
8. Glass Ionomer Cements/
9. (glass adj ionomer$).mp.
10. or/4-9
11. exp DENTAL ENAMEL SOLUBILITY/
12. TOOTH DEMINERALIZATION/
13. (reminerali$ or deminerali$ or decalcif$).mp.
14. ((white adj spot$) or lesion$).mp.
15. or/11-14
16. 3 and 10 and 15
The above subject search was linked to the Cochrane Oral Health Group filter for identifying RCTs in EMBASE via OVID.
1. random$.ti,ab.
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2. factorial$.ti,ab.
3. (crossover$ or cross over$ or cross-over$).ti,ab.
4. placebo$.ti,ab.
5. (doubl$ adj blind$).ti,ab.
6. (singl$ adj blind$).ti,ab.
7. assign$.ti,ab.
8. allocat$.ti,ab.
9. volunteer$.ti,ab.
10. CROSSOVER PROCEDURE.sh.
11. DOUBLE-BLIND PROCEDURE.sh.
12. RANDOMIZED CONTROLLED TRIAL.sh.
13. SINGLE BLIND PROCEDURE.sh.
14. or/1-13
15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/
16. HUMAN/
17. 16 and 15
18. 15 not 17
19. 14 not 18
Appendix 5. US National Institutes of Health Trials Register search strategy
We used the search terms “orthodontic* and fluoride” to search this database on 25 June 2013 (http://clinicaltrials.gov).
WH A T ’ S N E W
Last assessed as up-to-date: 31 January 2013.
Date Event Description
3 December 2013 New citation required and conclusions have changed Changes to inclusion criteria, 3 parallel-group studies
added and 14 previously included studies now excluded.
New methods implemented and Summary of findings
table added. Conclusions changed
1 May 2013 New search has been performed Searches updated to January 2013.
C O N T R I B U T I O N S O F A U T H O R S
Philip Benson wrote the protocol and co-ordinated the review. Philip Benson, Fiona Dyer, Peter Germain, Declan Millett and Nicola
Parkin independently and in duplicate assessed the eligibility of trials, extracted data and assessed the quality of the trials. Philip Benson
contacted authors, entered the data, carried out the statistical analysis (with help from Helen Worthington) and wrote the review.
Declan Millett proofread the review.
For the 2013 update of this review, Philip Benson and Susan Furness contacted authors, assessed risk of bias, extracted and entered
data, carried out the statistical analysis (with help from Helen Worthington) and wrote the text of the review.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the 2013 update of this review, controlled clinical trials (quasi-randomised) were excluded.
A point of clarification was added to the inclusion criteria for this review. For a randomised controlled trial to be included, demineralised
white lesions (DWLs) must be assessed on teeth remaining in the mouth. Studies that evaluated demineralisation of extracted teeth
were excluded from the 2013 update of this review because they measured the effects of short-term exposure to fluoride (four to six
weeks between application and extraction of the teeth). Furthermore, it was decided that evaluation of demineralisation must take place
at the end of treatment with fixed orthodontic appliances (debonding).
As stated in the Discussion of the previous version of this review, the use of a split-mouth study design to evaluate these interventions
is potentially inappropriate. It is unlikely that the fluoride released will be confined to only the quadrants or the specific teeth in which
the experimental material has been placed, and some ’contamination’ of teeth in the control quadrants is inevitable. This will reduce the
difference in outcome between experimental and control teeth and will reduce the power of the trial to find a difference. Indeed split-
mouth studies included in the previous version of this review found no difference between teeth with fluoridated bracket adhesives and
those without, supporting the view that this design is inappropriate for evaluating topical fluorides. Split-mouth studies were excluded
from the 2013 update of this review, and the Methods sections of this review was amended to remove methods that were used to deal
with split-mouth studies.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
Dental Caries [∗prevention & control]; Fluorides [∗therapeutic use]; Mouthwashes [∗therapeutic use]; Orthodontic Brackets [∗adverse
effects]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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